23948sdkhjf
Log in or create to bookmark articles
Get access to all content on Life Science Focus
No commitment or card information required
Applies to personal subscription only.
Contact us for a enterprise solution.
Advertisement
Advertisement

GLP-1 drugs spark unexpected interest among perfume giants

The appetite-suppressing effects of weight-loss drugs are well known. But could they also change what people want to smell like? That question has now caught the attention of some of the world's biggest perfume manufacturers.
Advertisement

The interest comes amid growing use of GLP-1 drugs such as Wegovy and Mounjaro. Companies including Givaudan, IFF and L'Oréal are investigating whether changes in eating habits and sensory experiences could also influence consumers' perfume preferences.

This was reported by Reuters, which has explored how weight-loss drugs are affecting people's lives in ways that go far beyond their weight in a series of articles.

Advertisement Advertisement
BREAKING
{{ article.headline }}
0.058|